Hepatitis C virus (HCV) prevalence among populations at indirect or intermediate risk and special clinical populations in Egypt, in studies conducted pre and post the 2001. A: Graph depicting HCV prevalence among different populations at indirect or intermediate risk in Egypt. B: Graph depicting HCV prevalence among different special clinical populations1 in Egypt. In this figure, we included only stratified HCV prevalence measures, if these stratified measures were available. Otherwise, we included the overall prevalence measures in the study. 1Acronyms: BC: bladder cancer, CLD: chronic liver disease, CRF: chronic renal failure, CV: cutaneous vasculitis, GIB: gastrointestinal bleeding, GN: glomerulonephritis, HCC: hepatocellular carcinoma, HCCA:hilarcholangiocarcinoma, HL: Hodgkin’s lymphoma, KTP: kidney transplant patients, LD: liver diseae, LP:lichen planus, MDS: myelodysplastic syndrome NHL: non-Hodgkin’s lymphoma, RHD: rheumatic heart disease, SLE: systematic lupus erthymatosus.